Polymorphism of the N-acetyltransferase 2 gene, red meat intake, and the susceptibility of hepatocellular carcinoma

American Journal of Gastroenterology

Volumn 98, Issue 6, 2003, Pages 1417-1422

  Huang, Yi Shin ^a   Chern, Herng Der ^b   Wu, Jaw Ching ^b   Chao, Yee ^b   Huang, Yi Hsiang ^b   Chang, Full Young ^b   Lee, Shou Dong ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DIET; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEAT; NAT2 GENE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0037635211     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07452.x     Document Type: Article

References (32)

1. Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:217-85.
2. Department of Health, the Executive Yuan. Cancer registry annual report, Taiwan, 1997. Taipei, Taiwan: Department of Health, 2000.
3. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308.
4. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991;13:398-406.
5. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994;17:71-91.
6. Beasley RP. Hepatitis B virus: The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
7. Sugimura T, Sato S. Mutagens-carcinogens in food. Cancer Res 1983;43(suppl 24):S15-21.
8. Turesky RJ, Land NP, Butler MA, et al. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991;12:1839-45.
9. Hein DW, Doll MA, Rustan TD, et al. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferase. Carcinogenesis 1993;14:1633-8.
10. Aoyama T, Yamano S, Guzelian PS, et al. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proc Natl Acad Sci USA 1990;87:4790-3.
11. Crespi CL, Penman BW, Gelboin HV, et al. A tobacco smokederived nitrosamine, 4(methylnitrosamine)-1-(3-pyridil)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6. Carcinogenesis 1991;12:1197-201.
12. Yanagawa Y, Sawada M, Deguchi T, et al. Stable expression of human CYP1A2 and N-acetyltransferase in Chinese hamster CHL cells: Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res 1994;54:3422-7.
13. Agundez JAG, Olivera M, Ladero JM, et al. Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers. Pharmacogenetics 1996;6:501-12.
14. Yu MW, Pai CI, Yang SY, et al. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: Impact of smoking on risk. Gut 2000;47:703-9.
15. Yu MW, Cladek-Yarborough A, Chiamprasert S, et al. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 1995;109:1266-73.
16. Yu MW, Chiu YH, Yang SY, et al. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer 1999;80:598-603.
17. Gunawardhana L, Barr J, Weir AJ, et al. The N-acetylation of sulfamethazine and p-aminobenzoic acid by human liver slices in dynamic organ culture. Drug Metab Disopos 1991;19:648-54.
18. Chen J, Stampfer MJ, Hough HL, et al. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 1998;58:3307-11.
19. Giovannucci E, Rimm EB, Stampfer MJ, et al. Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res 1994;54:2390-7.
20. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semi-quantitative food frequency questionnaire. J Am Diet Assoc 1993;93:790-6.
21. Bell DA, Taylor JA, Butler MA, et al. Genotype/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 1993;14:1689-92.
22. Caporaso N, Landi MT, Vineis P. Relevance of metabolic polymorphisms to human carcinogenesis: Evaluation of epidemiologic evidence. Pharmacogenetics 1991;1:4-19.
23. Brockmoller J, Cascorbi I, Kerb R, et al. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 1996;56:3915-25.
24. Ilett KF, David BM, Detchon P, et al. Acetylation phenotype in colorectal carcinoma. Cancer Res 1987;47:1466-9.
25. Lang NP, Butler MA, Massengill J, et al. Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol Biomar 1994;3:675-82.
26. Bell DA, Stephens EA, Castranio T, et al. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res 1995;55:3537-42.
27. Welfare MR, Cooper J, Bassendine MF, et al. Relationship between acetylator status, smoking, diet and colorectal cancer risk in the north-east of England. Carcinogenesis 1997;18: 1351-4.
28. Ohgaki H, Kusama K, Matsukura N, et al. Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f] quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis 1984;5:921-4.
29. Ohgaki H, Hasegawa H, Suenaga M, et al. Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis 1987;8:665-8.
30. Kato T, Ohgaki H, Hasegawa H, et al. Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline. Carcinogenesis 1988;9:71-3.
31. Rothman N, Hayes RB, Bi W, et al. Correlation between N-acetyltransferase activity and NAT2 genotype in Chinese males. Pharmacogenetics 1993;3:250-5.
32. Lin HJ, Han CY, Lin BK, et al. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 1994;4:125-34.